Novel derivatives of diosgenin: design, synthesis and anti-tumor activity.
- Author:
Xiao-Yong DING
1
;
Gu HE
;
Hong-Ping JIANG
;
Jian-Fei WAN
;
Ju-Zheng FAN
Author Information
1. Department of Medicinal Chemistry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
chemical synthesis;
chemistry;
pharmacology;
Cell Line, Tumor;
Diosgenin;
analogs & derivatives;
chemical synthesis;
chemistry;
pharmacology;
Drug Design;
Humans
- From:
Acta Pharmaceutica Sinica
2012;47(4):479-485
- CountryChina
- Language:Chinese
-
Abstract:
Diosgenin can inhibit the growth of A375 and K562 cell lines and induce their apoptosis with an effect on pro-apoptotic members of Bcl-2 family. To study the SAR of diosgenin derivatives, and to improve the anti-tumor activity of diosgenin, a series of novel diosgenin derivatives were designed and synthesized. Their anti-tumor activities in vitro were evaluated. The results revealed that most of the new derivatives had potent effects against K562, A375 and A549 (three tumor cell lines) in vitro, and had no or less effect against H293 and L02 (two normal cell lines). Particularly, some compounds (e.g. 1, 6-8) showed excellent activities on K562 with IC50 values ranging from 1.96 to 4.35 micromol x L(-1).
